Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beta-lactamase (Escherichia coli) | BDBM50140673 ((2S,5R,6S)-6-Mercaptomethyl-3,3-dimethyl-7-oxo-4-t...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Southern Methodist University Curated by ChEMBL | Assay Description Beta-Lactamase inhibitory activity against representativeclass C (P99) serine enzyme | Bioorg Med Chem Lett 14: 1299-304 (2004) Article DOI: 10.1016/j.bmcl.2003.12.037 BindingDB Entry DOI: 10.7270/Q22Z14ZG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metallo-beta-lactamase L1 type 3 (Stenotrophomonas maltophilia) | BDBM50140666 ((2S,5R,6S)-6-Mercaptomethyl-3,3-dimethyl-4,4,7-tri...) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Southern Methodist University Curated by ChEMBL | Assay Description Inhibition of class B (BCII) metallo-beta-lactamase representative enzyme | Bioorg Med Chem Lett 14: 1299-304 (2004) Article DOI: 10.1016/j.bmcl.2003.12.037 BindingDB Entry DOI: 10.7270/Q22Z14ZG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Beta-lactamase TEM (Escherichia coli) | BDBM50157692 (CHEMBL1439 | CL-307579 | Sodium; (2S,3S,5R)-3-meth...) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 122 | n/a | n/a | n/a | n/a | n/a | n/a |
Southern Methodist University Curated by ChEMBL | Assay Description Beta-Lactamase inhibitory activity against representative class A (TEM-1) serine enzyme | Bioorg Med Chem Lett 14: 1299-304 (2004) Article DOI: 10.1016/j.bmcl.2003.12.037 BindingDB Entry DOI: 10.7270/Q22Z14ZG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metallo-beta-lactamase L1 type 3 (Stenotrophomonas maltophilia) | BDBM50140668 ((2S,5R,6R)-6-Mercaptomethyl-3,3-dimethyl-4,4,7-tri...) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Southern Methodist University Curated by ChEMBL | Assay Description Beta-Lactamase Inhibition of metallo-beta-lactamase representative class B (L1) enzyme | Bioorg Med Chem Lett 14: 1299-304 (2004) Article DOI: 10.1016/j.bmcl.2003.12.037 BindingDB Entry DOI: 10.7270/Q22Z14ZG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Metallo-beta-lactamase type 2 (Bacillus cereus) | BDBM50140668 ((2S,5R,6R)-6-Mercaptomethyl-3,3-dimethyl-4,4,7-tri...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Southern Methodist University Curated by ChEMBL | Assay Description Beta-Lactamase Inhibition of metallo-beta-lactamase representative class B (L1) enzyme | Bioorg Med Chem Lett 14: 1299-304 (2004) Article DOI: 10.1016/j.bmcl.2003.12.037 BindingDB Entry DOI: 10.7270/Q22Z14ZG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Beta-lactamase TEM (Escherichia coli) | BDBM50076678 ((2S,5R,6R)-6-Hydroxymethyl-3,3-dimethyl-4,4,7-trio...) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 650 | n/a | n/a | n/a | n/a | n/a | n/a |
Southern Methodist University Curated by ChEMBL | Assay Description Beta-Lactamase inhibitory activity against representative class A (TEM-1) serine enzyme | Bioorg Med Chem Lett 14: 1299-304 (2004) Article DOI: 10.1016/j.bmcl.2003.12.037 BindingDB Entry DOI: 10.7270/Q22Z14ZG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109055 (US9695205, 1) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109056 (US9695205, 2) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109057 (US9695205, 3) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109058 (US9695205, 4) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109059 (US9695205, 5) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109061 (US9695205, 6) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109091 (US9695205, 7) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109092 (US9695205, 8) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109093 (US9695205, 9) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109094 (US9695205, 10) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109103 (US9695205, 11) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109104 (US9695205, 12) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109178 (US9695205, 13) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109199 (US9695205, 14) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109358 (US9695205, 15) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109385 (US9695205, 16) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109391 (US9695205, 17) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109393 (US9695205, 18) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109466 (US9695205, 19) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109468 (US9695205, 20) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109469 (US9695205, 21) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109544 (US9695205, 22) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109545 (US9695205, 23) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109940 (US9695205, 24) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM109944 (US9695205, 25) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM110039 (US9695205, 26) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM110040 (US9695205, 27) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM110042 (US9695205, 28) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM110043 (US9695205, 29) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM110146 (US9695205, 30) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM111048 (US9695205, 31) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM111049 (US9695205, 32) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM111050 (US9695205, 33) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM111052 (US9695205, 34) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM111053 (US9695205, 35) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM111054 (US9695205, 36) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM111055 (US9695205, 37) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM111056 (US9695205, 38) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM111057 (US9695205, 39) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM111058 (US9695205, 40) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM111060 (US9695205, 41) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM111061 (US9695205, 42) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM111062 (US9695205, 43) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Complement factor D (Homo sapiens (Human)) | BDBM111063 (US9695205, 44) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Achillion Pharmaceuticals, Inc. US Patent | Assay Description Human factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce... | US Patent US9695205 (2017) BindingDB Entry DOI: 10.7270/Q2VQ30TH | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 4091 total ) | Next | Last >> |